These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21799330)

  • 1. Electronic toxicity monitoring and patient-reported outcomes.
    Basch EM; Reeve BB; Mitchell SA; Clauser SB; Minasian L; Sit L; Chilukuri R; Baumgartner P; Rogak L; Blauel E; Abernethy AP; Bruner D
    Cancer J; 2011; 17(4):231-4. PubMed ID: 21799330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Online monitoring of patient self-reported adverse events in early phase clinical trials: Views from patients, clinicians, and trial staff.
    Kennedy F; Shearsmith L; Ayres M; Lindner OC; Marston L; Pass A; Danson S; Velikova G
    Clin Trials; 2021 Apr; 18(2):168-179. PubMed ID: 33231103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
    Basch E; Becker C; Rogak LJ; Schrag D; Reeve BB; Spears P; Smith ML; Gounder MM; Mahoney MR; Schwartz GK; Bennett AV; Mendoza TR; Cleeland CS; Sloan JA; Bruner DW; Schwab G; Atkinson TM; Thanarajasingam G; Bertagnolli MM; Dueck AC
    Clin Trials; 2021 Feb; 18(1):104-114. PubMed ID: 33258687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
    Chung AE; Shoenbill K; Mitchell SA; Dueck AC; Schrag D; Bruner DW; Minasian LM; St Germain D; O'Mara AM; Baumgartner P; Rogak LJ; Abernethy AP; Griffin AC; Basch EM
    J Am Med Inform Assoc; 2019 Apr; 26(4):276-285. PubMed ID: 30840079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
    Bruner DW; Hanisch LJ; Reeve BB; Trotti AM; Schrag D; Sit L; Mendoza TR; Minasian L; O'Mara A; Denicoff AM; Rowland JH; Montello M; Geoghegan C; Abernethy AP; Clauser SB; Castro K; Mitchell SA; Burke L; Trentacosti AM; Basch EM
    Transl Behav Med; 2011 Mar; 1(1):110-22. PubMed ID: 24073038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events: Methods for item selection in industry-sponsored oncology clinical trials.
    Trask PC; Dueck AC; Piault E; Campbell A
    Clin Trials; 2018 Dec; 15(6):616-623. PubMed ID: 30230365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an integrated electronic platform for patient self-report and management of adverse events during cancer treatment.
    Holch P; Warrington L; Bamforth LCA; Keding A; Ziegler LE; Absolom K; Hector C; Harley C; Johnson O; Hall G; Morris C; Velikova G
    Ann Oncol; 2017 Sep; 28(9):2305-2311. PubMed ID: 28911065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study.
    Basch E; Iasonos A; McDonough T; Barz A; Culkin A; Kris MG; Scher HI; Schrag D
    Lancet Oncol; 2006 Nov; 7(11):903-9. PubMed ID: 17081915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-Reported Outcomes in Cancer Clinical Trials: Measuring Symptomatic Adverse Events With the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
    Kluetz PG; Chingos DT; Basch EM; Mitchell SA
    Am Soc Clin Oncol Educ Book; 2016; 35():67-73. PubMed ID: 27249687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asking the right questions to get the right answers: using cognitive interviews to review the acceptability, comprehension and clinical meaningfulness of patient self-report adverse event items in oncology patients.
    Holch P; Warrington L; Potrata B; Ziegler L; Hector C; Keding A; Harley C; Absolom K; Morris C; Bamforth L; Velikova G
    Acta Oncol; 2016; 55(9-10):1220-1226. PubMed ID: 27551774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative.
    Reeve BB; McFatrich M; Pinheiro LC; Weaver MS; Sung L; Withycombe JS; Baker JN; Mack JW; Waldron MK; Gibson D; Tomlinson D; Freyer DR; Mowbray C; Jacobs S; Palma D; Martens CE; Gold SH; Jackson KD; Hinds PS
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27650708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the German patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™).
    Hagelstein V; Ortland I; Wilmer A; Mitchell SA; Jaehde U
    Ann Oncol; 2016 Dec; 27(12):2294-2299. PubMed ID: 27681863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinician versus nurse symptom reporting using the National Cancer Institute-Common Terminology Criteria for Adverse Events during chemotherapy: results of a comparison based on patient's self-reported questionnaire.
    Cirillo M; Venturini M; Ciccarelli L; Coati F; Bortolami O; Verlato G
    Ann Oncol; 2009 Dec; 20(12):1929-35. PubMed ID: 19622510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Danish Translation and Linguistic Validation of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
    Bæksted C; Nissen A; Pappot H; Bidstrup PE; Mitchell SA; Basch E; Dalton SO; Johansen C
    J Pain Symptom Manage; 2016 Aug; 52(2):292-7. PubMed ID: 27090851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping child and adolescent self-reported symptom data to clinician-reported adverse event grading to improve pediatric oncology care and research.
    McFatrich M; Brondon J; Lucas NR; Hinds PS; Maurer SH; Mack JW; Freyer DR; Jacobs SS; Baker JN; Mowbray C; Wang M; Castellino SM; Barz Leahy A; Reeve BB
    Cancer; 2020 Jan; 126(1):140-147. PubMed ID: 31553494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engaging Patients and Clinicians in Online Reporting of Adverse Effects During Chemotherapy for Cancer: The eRAPID System (Electronic Patient Self-Reporting of Adverse Events: Patient Information and aDvice).
    Absolom K; Gibson A; Velikova G
    Med Care; 2019 May; 57 Suppl 5 Suppl 1():S59-S65. PubMed ID: 30985598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods for Implementing and Reporting Patient-reported Outcome (PRO) Measures of Symptomatic Adverse Events in Cancer Clinical Trials.
    Basch E; Rogak LJ; Dueck AC
    Clin Ther; 2016 Apr; 38(4):821-30. PubMed ID: 27045992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy.
    Basch E; Iasonos A; Barz A; Culkin A; Kris MG; Artz D; Fearn P; Speakman J; Farquhar R; Scher HI; McCabe M; Schrag D
    J Clin Oncol; 2007 Dec; 25(34):5374-80. PubMed ID: 18048818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability and Validity of the Korean Language Version of the U.S. National Cancer Institute's Patient-Reported Outcomes Common Terminology Criteria for Adverse Events.
    Yoon J; Sim SH; Kang D; Han G; Kim Y; Ahn J; Oh D; Lee ES; Kong SY; Cho J; Mitchell SA
    J Pain Symptom Manage; 2020 May; 59(5):1082-1088.e6. PubMed ID: 32044423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.